)
Visual
test
Lincoln Pharmaceuticals
Lincoln Pharmaceuticals (531633) investor relations material
Lincoln Pharmaceuticals Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary13 Nov, 2025
Executive summary
Consolidated net profit for Q2 FY26 was Rs. 20.01 crore, down 24.06% year-over-year; total income for the quarter was Rs. 170.60 crore, a slight decrease of 0.34% year-over-year.
For the half year ended September 2025, consolidated net profit was Rs. 47.71 crore, down 4.64% year-over-year, with total income rising 3.36% to Rs. 339.93 crore.
The company targets Rs. 1,000 crore revenue in three years, aiming for 15-18% annual growth, focusing on cardiac, diabetic, dermatology, and ENT segments.
Dividend of Rs. 1.80 per share for FY24-25 approved at the 31st AGM.
FIIs increased their holding to 4.73% as of September 30, 2025.
Financial highlights
Q2 FY26 EBITDA was Rs. 32.66 crore, down 14.86% year-over-year; H1 FY26 EBITDA was Rs. 71.74 crore, up 0.34% year-over-year.
Q2 FY26 EPS was Rs. 9.98, down 24.11% year-over-year; H1 FY26 EPS was Rs. 23.79, down 4.69% year-over-year.
Standalone net profit for H1 FY26 was Rs. 47.71 crore, down 4.64% year-over-year; total income for H1 FY26 was Rs. 339.93 crore, up 3.36%.
As of September 30, 2025, consolidated total assets stood at Rs. 85,450.90 lakh, with equity of Rs. 71,576.82 lakh.
Cash and cash equivalents increased to Rs. 2,027.90 lakh at the end of H1 FY26.
Outlook and guidance
Management reiterates a strategic goal of Rs. 1,000 crore revenue within three years, supported by expansion into high-value therapeutic segments and new markets.
Company expects to maintain 15-18% annual growth, leveraging R&D, operational excellence, and a strong product pipeline.
Plans to expand exports from 60+ to 90 countries in the next 2-3 years, with recent entry into Canada and regulatory approvals from TGA-Australia and EU GMP.
Reconcile Q2 profit decline with 15-18% growth target
Impact of capex on cash flow and future returns
What drives FII interest despite Q2 profit dip?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026. - 6 FebARI
Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy. - 6 FebSMCI
Q2 revenue jumped 123% to $12.7B, with FY26 guidance raised to at least $40B. - 6 FebRJF
Record revenues and assets, higher dividend, and acquisitions despite lower net income. - 6 FebFFIE
Raising capital for global EV and AI expansion, with regulatory and dilution risks highlighted.
Next Lincoln Pharmaceuticals earnings date
Q3 25/2612 Feb, 2026
Lincoln Pharmaceuticals
Next Lincoln Pharmaceuticals earnings date
Q3 25/2612 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Lincoln Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical formulations. The company produces a wide range of dosage forms including tablets, capsules, injectables, creams, and syrups across various therapeutic categories such as anti-infectives, gastrointestinal, cardiovascular, and dermatology. It serves both domestic and international markets and operates manufacturing facilities that comply with regulatory standards. Lincoln Pharmaceuticals Limited also provides contract manufacturing services to other pharmaceutical companies. The company is headquartered in Ahmedabad, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage